Clinical Trial Update: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating autologous adipose-derived stem/stromal cells for chronic lung disease has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease

Snippet

Sponsor: Healeon Medical Inc | Conditions: Lung Disease | Phase 1, Phase 2 | Status: SUSPENDED